Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-24 @ 5:44 PM
NCT ID:
NCT02075268
Brief Summary:
An open label, parallel study to characterize the pharmacokinetics and pharmacodynamics of Prasugrel 30 mg or 60 mg in healthy male adult subjects
Detailed Description:
1. Screening
2. Enrollment and treatment randomization
3. Confinement to Research Unit from day - 1 to day 2
4. Outpatient visit : 2 times ( 48 and 73 hours after dosing)
5. Drug administration : Overnight Fasting
6. Blood sampling for PK, PD and genotyping
1. PK: up to 24 hours after dosing
2. PD: up to 72 hours after dosing
Study:
NCT02075268
Study Brief:
Protocol Section:
NCT02075268